Japanese pharmaceutical companies have an eye on the OTC market in Korea

Japanese pharmaceutical companies have an eye on the OTC market in Korea.

Kowa Korea plans to focus on OTC sales. On June 2, Kowa Korea officially launched Cabagin Kowa S tablet in Korea market which contains cabbage origin ingredient MMS, and challenges in earnest.

Takeda Korea which succeeded in sales of Whituben is preparing a new OTC product. They received approval of Actinum EX Plus Tabl...